Ok_老虎社区_美港股上老虎

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":605957478,"tweetId":"605957478","gmtCreate":1639105059805,"gmtModify":1639106292443,"author":{"id":3555327015224476,"idStr":"3555327015224476","authorId":3555327015224476,"authorIdStr":"3555327015224476","name":"rustic","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":18,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Ok</p></body></html>","htmlText":"<html><head></head><body><p>Ok</p></body></html>","text":"Ok","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/605957478","repostId":1118435301,"repostType":4,"repost":{"id":"1118435301","kind":"news","pubTimestamp":1639104912,"share":"https://www.laohu8.com/m/news/1118435301?lang=zh_CN&edition=full","pubTime":"2021-12-10 10:55","market":"hk","language":"en","title":"Chinese Drugmaker Asymchem Slips in Hong Kong Trading Debut<blockquote>中国制药商凯莱英在香港首次交易中下滑</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1118435301","media":"Bloomberg","summary":"(Bloomberg) -- Chinese contract drug manufacturer Asymchem Laboratories Tianjin Co. dropped in its f","content":"<p>(Bloomberg) -- Chinese contract drug manufacturer Asymchem Laboratories Tianjin Co. dropped in its first day of trading in Hong Kong, after completing the Asian financial hub’s biggest initial public offering in more than two months.</p><p><blockquote>（彭博社）——中国合同药品制造商凯莱英医药天津股份有限公司在香港完成了亚洲金融中心两个多月来最大的首次公开募股后，在香港首日交易中下跌。</blockquote></p><p> The shares fell as much as 4.5% to HK$370.40 on Friday. They were sold at HK$388 apiece in an IPO that raised about HK$7.15 billion ($917 million). The H-shares had been marketed at between HK$350 and HK$410 and were ultimately priced at a discount of 34% to Asymchem’s Shenzhen-listed stock.</p><p><blockquote>该股周五一度下跌4.5%，至370.40港元。它们在IPO中以每张388港元的价格出售，筹集了约71.5亿港元（9.17亿美元）。H股的市场价格在350港元至410港元之间，最终定价较凯莱英在深圳上市的股票折价34%。</blockquote></p><p> Asymchem is the largest IPO in Hong Kong since Dongguan Rural Commercial Bank Co.’s $1.2 billion deal in September. Hong Kong’s exchange has hosted few large offerings in recent months as Beijing’s clampdowns on various industries soured sentiment in both the primary and secondary markets.</p><p><blockquote>凯莱英是自东莞农村商业银行股份有限公司9月份12亿美元交易以来在香港最大的IPO。近几个月来，由于北京方面对多个行业的打压恶化了一级和二级市场的情绪，香港交易所几乎没有进行过大型发行。</blockquote></p><p> Twelve of 16 IPOs in the city since August raising over $100 million each ended their first session below their listing price, according to data compiled by Bloomberg as of Thursday.</p><p><blockquote>根据彭博社截至周四汇编的数据，自8月份以来，该市16起IPO中，有12起首次公开募股融资超过1亿美元，首日收盘价均低于上市价格。</blockquote></p><p> Asymchem, a Tianjin-based contract development and manufacturing organization (CDMO) for the drug industry, plans to use proceeds to add capacity and capabilities as well as increase market share. Goldman Sachs Group Inc. and Citic Securities Co. were joint sponsors for the share sale.</p><p><blockquote>凯莱英是一家总部位于天津的药品行业合同开发和制造组织（CDMO），计划利用所得款项增加产能和能力并增加市场份额。高盛集团和中信证券公司是此次股份出售的联席保荐人。</blockquote></p><p> Two other smaller debuts in Hong Kong on Friday had mixed performance. Gushengtang Holdings Ltd., a traditional Chinese medicine healthcare service provider, jumped as much as 18% following a $104 million offering. CANbridge Pharmaceuticals Inc., a biopharmaceutical company, dropped as much as 29% following an $88 million IPO.</p><p><blockquote>周五在香港首次亮相的另外两家规模较小的公司表现好坏参半。中药医疗保健服务提供商固生堂控股有限公司在发行1.04亿美元后股价上涨18%。生物制药公司CANbridge Pharmaceuticals Inc.在IPO 8800万美元后股价下跌29%。</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chinese Drugmaker Asymchem Slips in Hong Kong Trading Debut<blockquote>中国制药商凯莱英在香港首次交易中下滑</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChinese Drugmaker Asymchem Slips in Hong Kong Trading Debut<blockquote>中国制药商凯莱英在香港首次交易中下滑</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-12-10 10:55</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Bloomberg) -- Chinese contract drug manufacturer Asymchem Laboratories Tianjin Co. dropped in its first day of trading in Hong Kong, after completing the Asian financial hub’s biggest initial public offering in more than two months.</p><p><blockquote>（彭博社）——中国合同药品制造商凯莱英医药天津股份有限公司在香港完成了亚洲金融中心两个多月来最大的首次公开募股后，在香港首日交易中下跌。</blockquote></p><p> The shares fell as much as 4.5% to HK$370.40 on Friday. They were sold at HK$388 apiece in an IPO that raised about HK$7.15 billion ($917 million). The H-shares had been marketed at between HK$350 and HK$410 and were ultimately priced at a discount of 34% to Asymchem’s Shenzhen-listed stock.</p><p><blockquote>该股周五一度下跌4.5%，至370.40港元。它们在IPO中以每张388港元的价格出售，筹集了约71.5亿港元（9.17亿美元）。H股的市场价格在350港元至410港元之间，最终定价较凯莱英在深圳上市的股票折价34%。</blockquote></p><p> Asymchem is the largest IPO in Hong Kong since Dongguan Rural Commercial Bank Co.’s $1.2 billion deal in September. Hong Kong’s exchange has hosted few large offerings in recent months as Beijing’s clampdowns on various industries soured sentiment in both the primary and secondary markets.</p><p><blockquote>凯莱英是自东莞农村商业银行股份有限公司9月份12亿美元交易以来在香港最大的IPO。近几个月来，由于北京方面对多个行业的打压恶化了一级和二级市场的情绪，香港交易所几乎没有进行过大型发行。</blockquote></p><p> Twelve of 16 IPOs in the city since August raising over $100 million each ended their first session below their listing price, according to data compiled by Bloomberg as of Thursday.</p><p><blockquote>根据彭博社截至周四汇编的数据，自8月份以来，该市16起IPO中，有12起首次公开募股融资超过1亿美元，首日收盘价均低于上市价格。</blockquote></p><p> Asymchem, a Tianjin-based contract development and manufacturing organization (CDMO) for the drug industry, plans to use proceeds to add capacity and capabilities as well as increase market share. Goldman Sachs Group Inc. and Citic Securities Co. were joint sponsors for the share sale.</p><p><blockquote>凯莱英是一家总部位于天津的药品行业合同开发和制造组织（CDMO），计划利用所得款项增加产能和能力并增加市场份额。高盛集团和中信证券公司是此次股份出售的联席保荐人。</blockquote></p><p> Two other smaller debuts in Hong Kong on Friday had mixed performance. Gushengtang Holdings Ltd., a traditional Chinese medicine healthcare service provider, jumped as much as 18% following a $104 million offering. CANbridge Pharmaceuticals Inc., a biopharmaceutical company, dropped as much as 29% following an $88 million IPO.</p><p><blockquote>周五在香港首次亮相的另外两家规模较小的公司表现好坏参半。中药医疗保健服务提供商固生堂控股有限公司在发行1.04亿美元后股价上涨18%。生物制药公司CANbridge Pharmaceuticals Inc.在IPO 8800万美元后股价下跌29%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/chinese-drugmaker-asymchem-slips-hong-020055996.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://finance.yahoo.com/news/chinese-drugmaker-asymchem-slips-hong-020055996.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118435301","content_text":"(Bloomberg) -- Chinese contract drug manufacturer Asymchem Laboratories Tianjin Co. dropped in its first day of trading in Hong Kong, after completing the Asian financial hub’s biggest initial public offering in more than two months.\nThe shares fell as much as 4.5% to HK$370.40 on Friday. They were sold at HK$388 apiece in an IPO that raised about HK$7.15 billion ($917 million). The H-shares had been marketed at between HK$350 and HK$410 and were ultimately priced at a discount of 34% to Asymchem’s Shenzhen-listed stock.\nAsymchem is the largest IPO in Hong Kong since Dongguan Rural Commercial Bank Co.’s $1.2 billion deal in September. Hong Kong’s exchange has hosted few large offerings in recent months as Beijing’s clampdowns on various industries soured sentiment in both the primary and secondary markets.\nTwelve of 16 IPOs in the city since August raising over $100 million each ended their first session below their listing price, according to data compiled by Bloomberg as of Thursday.\nAsymchem, a Tianjin-based contract development and manufacturing organization (CDMO) for the drug industry, plans to use proceeds to add capacity and capabilities as well as increase market share. Goldman Sachs Group Inc. and Citic Securities Co. were joint sponsors for the share sale.\nTwo other smaller debuts in Hong Kong on Friday had mixed performance. Gushengtang Holdings Ltd., a traditional Chinese medicine healthcare service provider, jumped as much as 18% following a $104 million offering. CANbridge Pharmaceuticals Inc., a biopharmaceutical company, dropped as much as 29% following an $88 million IPO.","news_type":1,"symbols_score_info":{"06821":0.9}},"isVote":1,"tweetType":1,"viewCount":304,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/605957478"}